Stearic Acid

Stearic Acid

SCHEMBL374745

CCC(O)O.CCCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.77
PPARG P37231 7/20 0.77
PPARD Q03181 7/20 0.77
PPARA Q07869 7/20 0.77
HDAC11 Q96DB2 5/20 0.77
TSHR P16473 4/20 0.77
PTPN1 P18031 3/20 0.77
FABP4 P15090 3/20 0.77
ALDH1A1 P00352 2/20 0.77
TLR2 O60603 2/20 0.77
TDP1 Q9NUW8 2/20 0.77
FFAR1 O14842 2/20 0.77
FFAR4 Q5NUL3 2/20 0.77
KMT2A Q03164 2/20 0.77
ALOX15 P16050 2/20 0.77
HSD17B10 Q99714 2/20 0.77
SLC22A6 Q4U2R8 1/20 0.77
SLC22A8 Q8TCC7 1/20 0.77
MEN1 O00255 1/20 0.77
ESR1 P03372 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Heptanoate SCHEMBL29166029 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Octanoic Acid SCHEMBL31413964 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL29629591 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL4956795 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Octanoic Acid SCHEMBL770068 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL25339668 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Dodecanoate SCHEMBL4241627 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL769296 1.00 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Hexanoate SCHEMBL25362962 0.98 AKR1B1 (0.76) GPR84PPARGPPARDPPARAHDAC11
Sebacic Acid SCHEMBL2181971 0.93 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202961-B2 Alkylphenol for adjusting the molecular weight, and polycarbonate compositions having improved properties BAYER MATERIALSCIENCE AG (DE) 2012-06-19 US claimed
US-20100317776-A1 ALKYLPHENOL FOR ADJUSTING THE MOLECULAR WEIGHT, AND POLYCARBONATE COMPOSITIONS HAVING IMPROVED PROPERTIES BAYER MATERIALSCIENCE AG (DE) 2010-12-16 US claimed
EP-2593288-B2 APPARATUS AND PROCESS FOR PRODUCING PRODUCTS FROM PIGMENT-CONTAINING POLYMER MIXTURES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2025-04-16 EP disclosed
CN-116999377-A Use of caviar extract 拉普雷集团股份有限公司 2023-11-07 CN disclosed
CN-116999376-A Active substance combinations for cosmetic preparations 拉普雷集团股份有限公司 2023-11-07 CN disclosed
EP-3174935-B1 COPOLYCARBONATE COMPOUNDS WITH CYCLIC AND LINEAR OLIGOMERS AND IMPROVED OPTICAL PROPERTIES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-06-21 EP disclosed
EP-3174934-B1 COPOLYCARBONATE COMPOUNDS WITH CYCLIC AND LINEAR OLIGOMERS AND IMPROVED RHEOLOGICAL PROPERTIES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-06-14 EP disclosed
EP-3227374-B1 COPOLYCARBONATE COMPOUNDS WITH IMPROVED RHEOLOGICAL AND OPTICAL PROPERTIES CONTAINING DIGLYCEROLESTER COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-06-01 EP disclosed
EP-3387056-B1 POLYCARBONATE COMPOSITIONS CONTAINING POLYGLYCIDYL ETHER COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-05-04 EP disclosed
US-20210230363-A1 DERIVATIVES OF 1,3-PROPANEDIOL VANTAGE SPECIALTY CHEMICALS INC (US) 2021-07-29 US disclosed
EP-3848014-A1 WATER-SOLUBLE FULLERENE TOPICAL COMPOSITION Beijing Fullcan Biotechnology Co., Ltd (CN) 2021-07-14 EP disclosed
EP-2007210-A2 COMPOSITIONS COMPRISING MONO AND DI ESTERS OF BIOLOGICALLY-BASED 1.3-PROPANEDIOL DuPont Tate & Lyle Bio Products Company, LLC (US) 2008-12-31 EP disclosed
WO-2008123845-A2 COMPOSITIONS COMPRISING MONO AND DI ESTERS OF BIOLOGICALLY-BASED 1.3-PROPANEDIOL DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2008-10-16 WO disclosed
WO-2008061990-A2 COSMETIC COMPOSITION COMPRISING A PROLINE DERIVATIVE AND/OR A SALT OF THE SAID DERIVATIVE L'OREAL (FR) 2008-05-29 WO disclosed
US-20070213247-A1 Detergent and liquid soap compositions comprising biologically-based mono and di esters DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-09-13 US disclosed
US-20070207939-A1 Compositions comprising mono and di esters of biologically-based 1,3-propanediol DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-09-06 US disclosed
US-20070202580-A1 Synthesis of mono and di esters from biologically-produced 1,3-propanediol BARCLAYS BANK PLC, AS COLLATERAL AGENT 2007-08-30 US disclosed
US-20070203323-A1 Food compositions comprising biologically-based biodegradable 1,3-propanediol esters DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-08-30 US disclosed
US-20070203276-A1 Plasticizers comprising biologically-based mono and di esters DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-08-30 US disclosed
US-20070202073-A1 Personal care and cosmetics compositions comprising biologically-based mono and di esters DUPONT TATE &LYLE BIO PRODUCTS COMPANY, LLC 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230363-A1 DERIVATIVES OF 1,3-PROPANEDIOL BBOX1, PGD, DDT GPR84 4344/4885PPARG 1053/4885PPARD 253/4885
US-20070202580-A1 Synthesis of mono and di esters from biologically-produced 1,3-propanediol DECR1, DECR2, HSD17B12 GPR84 1943/4885PPARG 1145/4885PPARD 385/4885
US-20100317776-A1 ALKYLPHENOL FOR ADJUSTING THE MOLECULAR WEIGHT, AND POLYCARBONATE COMPOSITIONS HAVING IMPROVED PROPERTIES TUFM, UFM1, WASF2 GPR84 3385/4885PPARG 306/4885PPARD 1385/4885
US-20070202073-A1 Personal care and cosmetics compositions comprising biologically-based mono and di esters PBDC1, CUTA, EBP GPR84 2433/4885PPARG 234/4885PPARD 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.